Author
Listed:
- Lei Zhang
(The Scripps Research Institute
CTK Biotech, Inc.)
- Adriana Irimia
(The Scripps Research Institute
The Scripps Research Institute
The Scripps Research Institute)
- Lingling He
(The Scripps Research Institute
The Scripps Research Institute)
- Elise Landais
(The Scripps Research Institute
The Scripps Research Institute
International AIDS Vaccine Initiative)
- Kimmo Rantalainen
(The Scripps Research Institute)
- Daniel P. Leaman
(The Scripps Research Institute)
- Thomas Vollbrecht
(University of California)
- Armando Stano
(The Scripps Research Institute)
- Daniel I. Sands
(The Scripps Research Institute)
- Arthur S. Kim
(The Scripps Research Institute
Washington University School of Medicine)
- Pascal Poignard
(The Scripps Research Institute
The Scripps Research Institute
International AIDS Vaccine Initiative
Centre National de Recherche Scientifique and Centre Hospitalier Universitaire Grenoble Alpes)
- Dennis R. Burton
(The Scripps Research Institute
The Scripps Research Institute
The Scripps Research Institute
MIT and Harvard)
- Ben Murrell
(University of California
Tumor and Cell Biology, Karolinska Institutet)
- Andrew B. Ward
(The Scripps Research Institute
The Scripps Research Institute
The Scripps Research Institute)
- Jiang Zhu
(The Scripps Research Institute
The Scripps Research Institute)
- Ian A. Wilson
(The Scripps Research Institute
The Scripps Research Institute
The Scripps Research Institute
The Scripps Research Institute)
- Michael B. Zwick
(The Scripps Research Institute)
Abstract
The membrane-proximal external region (MPER) of HIV-1 envelope glycoprotein (Env) can be targeted by neutralizing antibodies of exceptional breadth. MPER antibodies usually have long, hydrophobic CDRH3s, lack activity as inferred germline precursors, are often from the minor IgG3 subclass, and some are polyreactive, such as 4E10. Here we describe an MPER broadly neutralizing antibody from the major IgG1 subclass, PGZL1, which shares germline V/D-region genes with 4E10, has a shorter CDRH3, and is less polyreactive. A recombinant sublineage variant pan-neutralizes a 130-isolate panel at 1.4 μg/ml (IC50). Notably, a germline revertant with mature CDR3s neutralizes 12% of viruses and still binds MPER after DJ reversion. Crystal structures of lipid-bound PGZL1 variants and cryo-EM reconstruction of an Env-PGZL1 complex reveal how these antibodies recognize MPER and viral membrane. Discovery of common genetic and structural elements among MPER antibodies from different patients suggests that such antibodies could be elicited using carefully designed immunogens.
Suggested Citation
Lei Zhang & Adriana Irimia & Lingling He & Elise Landais & Kimmo Rantalainen & Daniel P. Leaman & Thomas Vollbrecht & Armando Stano & Daniel I. Sands & Arthur S. Kim & Pascal Poignard & Dennis R. Burt, 2019.
"An MPER antibody neutralizes HIV-1 using germline features shared among donors,"
Nature Communications, Nature, vol. 10(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12973-1
DOI: 10.1038/s41467-019-12973-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12973-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.